E3リガスの未知結合ポケットの発見は,FBW7アロステリックモジュレータの識別につながった
Míriam Martínez-Cartró1,2, Álvaro Serrano-Morrás1,2, Andrea Bertran-Mostazo1,2
1Departament de Farmàcia i Tecnologia Farmacéutica, i Fisicoquímica. Facultat de Farmàcia i Ciències de l'Alimentació Universitat de Barcelona, Barcelona, 08028, Spain.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|August 20, 2025
まとめ
研究者は,標的型タンパク質の分解に不可欠なE3リガゼの薬効性アロステリックポケットを特定しました. FBW7を標的とした新しい小分子を発見し,c-MYCとc-JUNタンパク質の分解を強めた.
科学分野:
- 生物化学と分子生物学
- 薬の発見と開発
- 化学生物学
背景:
- E3リガスは,ユビキチン-プロテアソーム系 (UPS) の中心的な調節体であり,治療戦略の重要な標的となっています.
- 標的型タンパク質分解 (TPD) は,E3リガゼのリガンドを使用するが,E3リガゼには小分子調節剤が知られているのはわずかである.
- E3リガスの新しい結合可能な部位を特定することは,TPDアプリケーションの拡大に不可欠です.
研究 の 目的:
- 多様なE3リガゼの結合可能な表面を特定するための効率的な方法を開発する.
- 特にアロステルポケットをターゲットに,E3リガース活性に結合し,それを調節する新しい小分子を発見する.
- TPDにおけるアロステリックE3リガース調節体の治療的可能性を実証する.
主な方法:
- 潜在的アロステル結合ポケットを特定するために,構造的に異なる22のE3リガゼの計算スクリーニング.
- FBW7を中心に,特定されたアロステリックポケットを標的とした小分子合成と特徴付け.
- 結合相互作用を確認するための生体物理学的および構造的分析 (例えば,X線結晶学).
- タンパク質の分解経路 (例えば,c-MYC,c-JUN) に対する小分子の影響を評価するための細胞ベースの機能分析.
主要な成果:
- 効率的なアプローチにより,22の多様なE3リガゼで有意なアロステル結合の機会が特定されました.
- FBW7におけるアロステリックポケットを標的とした最初の強力で逆転可能な小分子結合物質が発見されました.
- これらのFBW7結合物質は,生体物理学的および構造的研究によって確認された.
- 機能的測定では,いくつかの調節剤は,c-MYCとc-JUNのFBW7依存性分解を強化することが示された.
結論:
- アロステリックポケットは,小分子によるE3リガゼをターゲットにするためのほとんど未使用のリソースを表しています.
- 発見されたアロステリックFBW7調節器は,TPD分野における新しい作用機構を提供する.
- これらの分子は,新しいPROTAC (タンパク質分解標的キメラ) および他のTPD治療薬の開発のための潜在的なハンドルとして機能します.
関連する概念動画
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
Cooperative Allosteric Transitions
8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K
Conserved Binding Sites
4.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
Allosteric Regulation
59.0K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
59.0K


